Cell-dose−dependent increases in circulating levels of immune effector cells in rhesus macaques following intracranial injection of allogeneic MSCs
- 31 October 2010
- journal article
- Published by Elsevier BV in Experimental Hematology
- Vol. 38 (10), 957-967.e1
- https://doi.org/10.1016/j.exphem.2010.06.011
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Mesenchymal stem cell therapy: Two steps forward, one step backTrends in Molecular Medicine, 2010
- HSCT Recipients Have Specific Tolerance to MSC but not to the MSC DonorJournal of Immunotherapy, 2009
- Murine Bone Marrow Stromal Progenitor Cells Elicit an In Vivo Cellular and Humoral Alloimmune ResponseTransplantation and Cellular Therapy, 2007
- Immunoregulatory function of mesenchymal stem cellsEuropean Journal of Immunology, 2006
- Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative settingBlood, 2006
- Allogeneic marrow stromal cells are immune rejected by MHC class I– and class II–mismatched recipient miceBlood, 2005
- Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergyPublished by American Society of Hematology ,2005
- NK CELL RECOGNITIONAnnual Review of Immunology, 2005
- The Molecular Basis of AllorecognitionAnnual Review of Immunology, 1993
- Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen).The Journal of Experimental Medicine, 1985